Cord Blood America, Inc., through its wholly owned subsidiaries, CorCell Companies Inc. and CorCell, Ltd., markets a service to preserve the umbilical cord blood in a patented process for future use exclusively by the donating family. The collection takes less than five minutes, is painless, easy and non-invasive.

Cryogenically preserved umbilical cord stem cells have already been used to treat 75 major diseases, including leukemia, severe anemia, metabolic blood disorders and immune deficiencies. This list is guaranteed to grow as medical research learns more about the incredible healing power of stem cells.

There is uniformity in the belief that stem cells will play a key role in fighting disease as we move into this century. Some scientists are confident that stem cells will launch a new era in medicine, perhaps even curing some of our most intractable diseases. The umbilical cord which, at birth, traditionally has been thrown away, contains a rich store of stem cells.

Cord blood has proven to contain the kind of stem cells that can be turned into red blood cells and disease-fighting white blood cells. They also totally avoid all the controversies involved with stem cells from other sources such as embryonic stem cells.

Besides current uses, medical research is ongoing on how to use these cells to combat heart disease, Parkinson’s disease, spinal cord injuries, sickle cell anemia, cancer and other difficult diseases to treat. Researchers postulate that the cells they remove from the umbilical cord blood can someday be turned into every single tissue in the body, making, for instance, the repair of a damaged heart possible, or facilitating recovery from a stroke by turning stem cells into brain cells.

Cord Blood America’s product is similar to an insurance policy, providing strong peace of mind. The preserved umbilical cord blood is saved specifically for the donating family.

2010 Growth Strategy

• Organic growth via building sales channels through insurance and medical providers
• Acquisitions - adding assets and revenues
• Diversifying revenue streams - from adding new forms of stem cell samples in storage such as adipose tissue, to adding subcontractors to store at our lab

Learn More.

Download and Read Our Investor Guide.

Cord Blood America, Inc.™ (CBAI) and its subsidiaries actively support the conservation of our natural resources. CBAI is committed to being diligent in our efforts to reduce our carbon footprint, both individually and as a company. We believe in conscientious water management and the preservation of Nevada’s natural resources.

CBAI has a corporate policy to use recycled products within all office locations and also the products that we produce whenever possible.

It is the goal of CBAI and the founding members to grow in our knowledge of preservation techniques and be respectful and responsible stewards of our environment not only for the benefit of Nevada and its community but also in the other states and countries in which CBAI operates.